Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2002; 40:1653-1659
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gillis, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gillis, A. M.

CLINICAL STUDY: ARRHYTHMIAS

Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator

Anne M. Gillis, MD*,*, Christina Unterberg-Buchwald, MD{dagger}, Herwig Schmidinger, MD{ddagger}, Santini Massimo, MD§, Kevin Wolfe, MD||, Deborah J. Kavaney, MS, Mary F. Otterness, MS, Stefan H. Hohnloser, MD** GEM III AT Worldwide Investigators

* Foothills Hospital and the University of Calgary, Calgary, Alberta, Canada
{dagger} Georg-August Universitätskliniken, Göttingen, Germany
{ddagger} Allgemeines Krankenhaus, Vienna, Austria
§ San Filippo Neri Hospital, Rome, Italy
|| Winnipeg Health Sciences Centre, Winnipeg, Manitoba, Canada
Medtronic Inc., Minneapolis, Minnesota, USA
** J. W. Goethe University, Department of Medicine, Division of Cardiology, Frankfurt, Germany

Manuscript received March 5, 2002; revised manuscript received May 21, 2002, accepted June 7, 2002.

* Reprint requests and correspondence: Dr. Anne M. Gillis, Division of Cardiology, The University of Calgary, 3330 Hospital Drive Northwest, Calgary, Alberta, Canada T2N 4N1.
amgillis{at}ucalgary.ca

OBJECTIVES: This study evaluated the safety and efficacy of atrial pacing therapies for the treatment and prevention of atrial tachycardia (AT) or atrial fibrillation (AF) in a new dual chamber implantable cardioverter defibrillator (ICD).

BACKGROUND: Patients with an ICD may also experience AT or AF that is amenable to pace termination.

METHODS: The efficacy of atrial antitachycardia pacing (ATP) therapies for atrial tachycardia or atrial fibrillation (AT/AF) was determined in 151 patients after implantation of a GEM III AT ICD (Medtronic Inc., Minneapolis, Minnesota). The percentage of episodes successfully terminated was adjusted for multiple episodes per patient.

RESULTS: A total of 717 of 728 (96%) episodes classified as AT or AF were judged to be appropriate detections. By device classification, atrial ATP terminated 187 of 383 (40% adjusted) episodes classified as AT compared with 65 of 240 episodes classified as AF (26% adjusted, p = 0.013). Atrial Ramp or Burst+ ATP terminated 184 of 378 episodes of AT (39% adjusted), whereas 50-Hz Burst pacing therapy terminated only 12 of 109 episodes of AT (12% adjusted) and 65 of 240 episodes of AF (26% adjusted). If efficacy was defined as termination of AT/AF within 20 s of delivery of the pacing therapy, ATP therapies terminated 139 of 383 (32% adjusted) episodes of AT compared with 34 of 240 episodes of AF (15% adjusted, p = 0.003). Efficacy was dependent on AT cycle length. Frequent transitions between AT and AF predicted inefficacy of atrial ATP (p < 0.001). Ventricular proarrhythmia secondary to atrial ATP was not observed.

CONCLUSIONS: Atrial ATP therapies terminate many episodes of AT without ventricular proarrhythmia. The addition of 50-Hz Burst pacing has minimal efficacy for AT/AF.

Abbreviations and Acronyms
  ACE
  angiotensin-converting enzyme
  AF
  atrial fibrillation
  AT
  atrial tachycardia
  AT/AF
  atrial tachycardia or atrial fibrillation
  ATP
  atrial tachycardia pacing
  CI
  confidence interval
  ICD
  implantable cardioverter defibrillator
  VF
  ventricular fibrillation
  VT
  ventricular tachycardia




This article has been cited by other articles:


Home page
CirculationHome page
F. H. Fenton, S. Luther, E. M. Cherry, N. F. Otani, V. Krinsky, A. Pumir, E. Bodenschatz, and R. F. Gilmour Jr
Termination of Atrial Fibrillation Using Pulsed Low-Energy Far-Field Stimulation
Circulation, August 11, 2009; 120(6): 467 - 476.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. M. Gillis, M. Morck, D. V. Exner, R. S. Sheldon, H. J. Duff, B. L. Mitchell, and G. D. Wyse
Impact of atrial antitachycardia pacing and atrial pace prevention therapies on atrial fibrillation burden over long-term follow-up
Europace, August 1, 2009; 11(8): 1041 - 1047.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]


Home page
EuropaceHome page
M. Gulizia, S. Mangiameli, S. Orazi, G. Chiaranda, G. Boriani, G. Piccione, N. DiGiovanni, A. Colletti, C. Puntrello, G. Butera, et al.
Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device
Europace, July 1, 2006; 8(7): 465 - 473.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
N. Musilli and L. Padeletti
Pacemaker selection: time for a rethinking of complex pacing systems?
Eur. Heart J., January 2, 2006; 27(2): 132 - 135.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
D. Vollmann, E. Kollet, L. Lüthje, S. Busse, and C. Unterberg
Comparison of immediate and delayed automatic antitachycardia pacing for the termination of atrial tachyarrhythmias
Europace, January 1, 2005; 7(3): 248 - 254.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement